Comparison of injectable and oral antipsychotics in relapse rates in a pragmatic 30-month schizophrenia relapse prevention study

Peter F Buckley, Nina R. Schooler, Donald C. Goff, Alex Kopelowicz, John Lauriello, Theo C. Manschreck, Alan Mendelowitz, Del D. Miller, Daniel R. Wilson, Donna Ames, Juan R. Bustillo, John M. Kane, Stephen Warwick Looney

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Objective: In a pragmatic clinical trial, this study sought t compare relapses among patients receiving either longactin injectable or oral second-generation antipsychotics Methods: PROACTIVE (Preventing Relapse Oral Antipsychotic Compared to Injectables Evaluating Efficacy), a prio 30-month relapse prevention study, compared use of long-Acting injectable second-generation antipsychoti with use of an oral second-generation antipsychotic by 30 patients with schizophrenia or schizoaffective disorder an found similar rates of first relapse between groups (42% wit injectable medication, 32% with oral medication). This stud examined subsequent relapses among patients who ha relapsed in PROACTIVE and who continued in treatment follow-up, or both Results: Thirty-Two patients (11%) experienced two relapses and 13 patients (4%) had three relapses. Neither rate of relaps nor time to successive relapses differed betwee treatment groups Conclusions: There was an impressively low rate of subsequen relapses in this pragmatic clinical trial. Becaus all patients had a clinic visit according to the biweekl long-Acting injectable medication administration schedule frequent contact may have contributed to low relapse rates Maintaining frequent clinical contact may be a valid psychosocia relapse prevention treatment.

Original languageEnglish (US)
Pages (from-to)1370-1372
Number of pages3
JournalPsychiatric Services
Volume67
Issue number12
DOIs
StatePublished - Dec 1 2016

    Fingerprint

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Buckley, P. F., Schooler, N. R., Goff, D. C., Kopelowicz, A., Lauriello, J., Manschreck, T. C., Mendelowitz, A., Miller, D. D., Wilson, D. R., Ames, D., Bustillo, J. R., Kane, J. M., & Looney, S. W. (2016). Comparison of injectable and oral antipsychotics in relapse rates in a pragmatic 30-month schizophrenia relapse prevention study. Psychiatric Services, 67(12), 1370-1372. https://doi.org/10.1176/appi.ps.201500466